Zobrazeno 1 - 10
of 45
pro vyhledávání: '"L Suchet"'
Autor:
Sandrine Wiertlewski, Christine Lebrun, M. Coustans, Pierre Labauge, Gilles Edan, Société Francophone de la Sclérose en Plaques, Pascal Derkinderen, Mikael Cohen, C Carra-Dallieres, Patrick Devos, F Lefrere, B Daumas-Duport, Patrick Vermersch, Hélène Zéphir, Eric Berger, Jean Pelletier, C Brosset, E Auffray-Calvier, Lucien Rumbach, P. Lejeune, Romain Deschamps, Emeline Duhin, J-B N'Kendjuo, David-Axel Laplaud, G Balloy, Olivier Gout, Laure Michel, L Suchet, E. Le Page, J. de Seze
Publikováno v:
Journal of Neurology
Journal of Neurology, Springer Verlag, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, Springer Verlag, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Tumefactive demyelinating lesions of the central nervous system can be the initial presentation in various pathological entities [multiple sclerosis (the most common), Balo’s concentric sclerosis, Schilder’s disease and acute disseminated encepha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007b19cf83d70f3b8d84a3399fab04fe
https://hal.archives-ouvertes.fr/hal-02066038
https://hal.archives-ouvertes.fr/hal-02066038
Autor:
Paulo Fontoura, V. Devonshire, Yves Lapierre, I. Balla, Richard A L Macdonell, Cristina Ramo-Tello, Elliot M. Frohman, Robert Hyde, Bernd C. Kieseier, L. Suchet, Francesco Patti
Publikováno v:
European Journal of Neurology. 18:69-77
Background: Most disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Astronautica. 36:541-544
The mission's success fully depends on the Payload Operations conducted during the space flight. The Ground Team has to be trained to assist the Space Crew, to replan the cosmonaut's activities when contingengies occurr onboard and to change or cance
Autor:
Mohamed Meite, Karin Rerat, F. Borgel, Thibault Moreau, L. Suchet, Olivier Heinzlef, Isabelle Bourdeix
Publikováno v:
Revue Neurologique. 170:A111-A112
Autor:
V, Devonshire, Y, Lapierre, R, Macdonell, C, Ramo-Tello, F, Patti, P, Fontoura, L, Suchet, R, Hyde, I, Balla, E M, Frohman, B C, Kieseier, A, Soto
Publikováno v:
European journal of neurology. 18(1)
most disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be addressed to
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 13(3)
Objective To analyse transcranial magnetic stimulation (TMS) variables in a prospective six-month follow-up pilot study on patients suffering from relapsing-remitting multiple sclerosis (RRMS), satisfying inclusion criteria for interferon (IFN) beta-
Publikováno v:
Revue neurologique. 160(1)
Oculodentodigital syndrome (ODD) is a rare congenital disorder which associates eyes and facial abnormalities, defects in teeth enamel and type III syndactyly. The causal genetic defect in this syndrome is still unknown. Some patients with ODD syndro
Publikováno v:
Revue neurologique. 159(8-9)
Hashimoto's encephalitis is a rare cause of encephalitis which is improved by corticosteroid treatment. We report the case of a 42-year-old woman who developed progressive dementia associated with episodes of recurrent discorders of consciousness whi
Autor:
G. Salamon, L. Suchet, Olivier Lyon-Caen, Michel Habib, Charles R.G. Guttmann, Tatiana Witjas, A. Ali Chérif, Jean Pelletier
Publikováno v:
Archives of neurology. 58(1)
Objectives To determine if callosal atrophy and interhemispheric dysfunction can be detected in the early stages of relapsing-remitting multiple sclerosis (MS) and to evaluate their progression in relation to the disability and evolution of lesions s